Evidence map›Paper›PMID 41232602›Full record

ArticleOphthalmology. Retina2026

Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact.

Leila Chew, Jeffrey Feng, Elizabeth Hutchins, Ashley F Stein-Merlob, Eric H Yang, Melissa G Lechner, Edmund Tsui

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ophthalmology. Retina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leila ChewDepartment of Ophthalmology, Stein Eye Institute, University of California, Los Angeles Health, University of California, Los Angeles, California.
Jeffrey FengDepartment of Radiological Sciences, Medical Imaging & Informatics Group, University of California, Los Angeles, California.
Elizabeth HutchinsUniversity of California, Los Angeles Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, California.
Ashley F Stein-MerlobUniversity of California, Los Angeles Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, California.
Eric H YangUniversity of California, Los Angeles Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, California.
Melissa G LechnerDivision of Endocrinology, Department of Medicine, University of California, Los Angeles, California.
Edmund TsuiDepartment of Ophthalmology, Stein Eye Institute, University of California, Los Angeles Health, University of California, Los Angeles, California. Electronic address: etsui@mednet.ucla.edu.

Funding

UCLA ACE Administrative CoreU19AI181729 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Maureen A Su · 2024 to 2026
$3.2M
Mechanisms of Thyroid Autoimmunity in Checkpoint ImmunotherapyK08DK129829 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LECHNER, MELISSA G · 2021 to 2025
$878k
NIAID NIH HHS U19 AI181729NIDDK NIH HHS K08 DK129829
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immune checkpoint inhibitorsImmunotherapyUveitis

Identifiers

PMID41232602
PMCPMC13180279

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.